Negatively Regulating the Cell Cycle Can Be Positive

Journal of the American Society of Nephrology

Volumn 15, Issue 5, 2004, Pages 1361-1362

  Hiromura, Keiju ^a   Shankland, Stuart J ^b  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYSTAUROSPORINE; ADENOVIRUS VECTOR; CYCLIN A; CYCLIN B; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLINE; FLAVOPIRIDOL; PROTEIN P15; PROTEIN P16; PROTEIN P21; PROTEIN P27; ROSCOVITINE;

APOPTOSIS; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG SAFETY; EDITORIAL; ENZYME ACTIVITY; GENE THERAPY; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HUMAN; HYPERTROPHY; IN VITRO STUDY; ISCHEMIA; KIDNEY DISEASE; KIDNEY FUNCTION; MALIGNANT NEOPLASTIC DISEASE; MESANGIUM CELL; MOLECULAR BIOLOGY; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEINURIA; REGULATORY MECHANISM; REPERFUSION; VIRUS INFECTION;

EID: 1942506476     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000126154.34286.D5     Document Type: Editorial

References (22)

1. Gherardi D, D'Agati V, Tearina Chu TH, Barnett A, Gianella-Borradori A, Gelman GH, Nelson PJ: Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol 15: 1212-1222, 2004
2. Shankland SJ: Cell cycle regulatory proteins in glomerular disease. Kidney Int 56: 1208-1215, 1999
3. Griffin SV, Pichler R, Dittrich M, Durvasula R, Shankland SJ: Cell cycle control in glomerular disease. Springer Semin Immunopathol 24: 441-457, 2003
4. Pines J: The cell cycle kinases. Semin Cancer Biol 5: 305-313, 1994
5. Hiromura K, Pippin JW, Fero ML, Roberts JM, Shankland SJ: Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kipl. J Clin Invest 103: 597-604, 1999
6. Meijer L, Leclerc S, Leost M: Properties and potential - applications of chemical inhibitors of cyclin-dependent kinases. Pharmacol Ther 82: 279-284, 1999
7. Vermeulen K, Van Bockstaele DR, Berneman ZN: The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 131-149, 2003
8. Brooks EE, Gray NS, Joly A, Kerwar SS, Lum R, Mackman RL, Norman TC, Rosete J, Rowe M, Schow SR, Schultz PG, Wang X, Wick MM, Shiffman D: CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. J Biol Chem 272: 29207-29211, 1997
9. Garcia-Perez J, Avila J, Diaz-Nido J: Implication of cyclin-dependent kinases and glycogen synthase kinase 3 in the phosphorylation of microtubule-associated protein IB in developing neuronal cells. J Neurosci Res 52: 445-452, 1998
10. Bresnahan WA, Boldogh I, Chi P, Thompson EA, Albrecht T: Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231: 239-247, 1997
11. Wei P, Garber ME, Fang SM, Fischer WH, Jones KA: A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92: 451-462, 1998
12. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, Notkins AL: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185: 109-119, 1991
13. Laurinavicius A, Rennke HG: Collapsing glomerulopathy - A new pattern of renal injury. Semin Diagn Pathol 19: 106-115, 2002
14. Nelson PJ, D'Agati VD, Gries JM, Suarez JR, Gelman IH: Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol. J Antimicrob Chemother 51: 921-929, 2003
15. Pippin JW, Qu Q, Meijer L, Shankland SJ: Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest 100: 2512-2520, 1997
16. Aydemir A, Abbasoglu O, Topaloglu S, Ertoy D, Ayhan A, Kilinc K, Karabulut E, Sayek I: Protective effect of roscovitine on renal ischemia-reperfusion injury. Transplant Proc 34: 2027-2028, 2002
17. Milovanceva-Popovska M, Kunter U, Ostendorf T, Petermann A, Rong S, Barnett A, Floege J: Inhibition of cyclin dependent kinase-2 (CDK2) by CYC202 (R-roscovitine) decreases cell proliferation but does not aggravate podocyte injury in experimental membranous nephropathy [Abstract]. J Am Soc Nephrol 14[Suppl]: 342A, 2003
18. Taniguchi K, Kohsaka H, Inoue N, Terada Y, Ito H, Hirokawa K, Miyasaka N: Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat Med 5: 760-767, 1999
19. Tsui LV, Camrud A, Mondesire J, Carlson P, Zayek N, Camrud L, Donahue B, Bauer S, Lin A, Frey D, Rivkin M, Subramanian A, Falotico R, Gyuris J, Schwartz R, McArthur JG: p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion. Circ Res 89: 323-328, 2001
20. Fan YP, Weiss RH: Exogenous attenuation of p21Waf1/Cip1 decreases mesangial cell hypertrophy as a result of hyperglycemia and IGF-1. J Am Soc Nephrol 15: 575-584, 2004
21. Price PM, Safirstein RL, Megyesi J: Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 286: F378-F384, 2004
22. Imai E: Gene therapy for renal diseases: Its potential and limitation. J Am Soc Nephrol 14: 1102-1104, 2003